Broadening access to cladribine should help more patients avoid hospital and free up clinic time.
USA TODAY on MSN14d
Christina Applegate, Selma Blair and John King have it. MS is more common than you think.Here's what MS is, what causes it and how you can expect the condition to be treated if it impacts you or someone you love.
You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...
In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
Biogen and AbbVie have announced the voluntary withdrawal of their multiple sclerosis drug Zinbryta from all markets worldwide following dangerous brain inflammation in seven patients in Europe.
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
A new study suggests that a simple treatment algorithm could significantly reduce disparities in multiple sclerosis care ...
The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results